JOURNAL OF CLINICAL SURGERY ›› 2023, Vol. 31 ›› Issue (6): 572-575.doi: 10.3969/j.issn.1005-6483.2023.06.020

Previous Articles     Next Articles

Expression levels and clinical diagnostic value of miR-3619-5p and LINC00857 in serum of hepatocellular carcinoma

  

  1. Department of General Surgery 2,Xi’an Central Hospital,Shaanxi,Xi’an 710003, China
  • Received:2022-06-20 Online:2023-06-20 Published:2023-06-20

Abstract: Objective To investigate the expression levels of microRNA-3619-5p(miR-3619-5p) and long noncoding RNA(LncRNA) LINC00857 in serum of hepatocellular carcinoma(HCC) and their clinical diagnostic value.Methods 78 patients with HCC,76 patients with benign liver lesions,and 78 patients with chronic liver disease were taken as HCC group,benign lesion group,and chronic liver disease group,respectively,another 78 healthy subjects who underwent physical examination were taken as the control group.The serum levels of miR-3619-5p,LncRNA LINC00857 and alpha-fetoprotein(AFP) in each group were compared;the diagnostic value of serum miR-3619-5p,LncRNA LINC00857 and AFP for HCC was analyzed.Results Comparison of serum miR-3619-5p [(1.05±0.35),(0.74±0.25),(0.72±0.24),(0.46±0.15)] and LncRNA LINC00,857 [(1.01±0.34),(1.62±0.54),(1.66±0.55),(2.95±0.98)],AFP [(3.13±1.14)μg/L,(48.86±16.29)μg/L,(50.23±18.74)μg/L,(301.25±117.23)μg/L] levels in patients with control group,chronic liver disease group,benign disease group,and HCC group,the difference was statistically significant(P<0.05).The areas under the curve(AUC) of serum miR-3619-5p,LncRNA LINC00857,and AFP for the diagnosis of HCC were 0.870,0.868,and 0.701,respectively,the AUC of serum miR-3619-5p combined with LncRNA LINC00857 to diagnose HCC was 0.956,the sensitivity was 94.9%,and the specificity was 86.4%.Conclusion The expression level of serum miR-3619-5p in HCC patients is low,while the expression level of LncRNA LINC00857 is high.The combination of miR-3619-5p and LncRNA LINC00857 may be more helpful for clinical diagnosis of HCC.

Key words: microRNA-3619-5p, hepatocellular carcinoma, long non-coding RNA LINC00857, diagnostic value

[1] LIU Jinwei, BA Linchao, ZHANG Jingfu, et al. Expression of hypoxia-induced lipid droplet-associated protein in hepatocellular carcinoma and clinical significance [J]. JOURNAL OF CLINICAL SURGERY, 2023, 31(5): 447-452.
[2] LIN Liyan, DONG Jia, XIAO Weijin, et al. Differential diagnosis of hepatocellular carcinoma and cholangiocarcinoma based on Mueller Matrix Polarimetry and machine learning [J]. JOURNAL OF CLINICAL SURGERY, 2023, 31(2): 164-167.
[3] YANG Gang, WANG Guan, XIONG Yongfu, et al. Study on the expression of TP53 regulation of apoptosis inhibitor 1 in hepatoma cells and its effect on proliferation and apoptosis [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(5): 471-474.
[4] LIN Meilong, WANG Wenqiang, LI Jian, et al. The diagnostic value of folate receptor-positive circulating tumor cells detection in patients with hepatocellular carcinoma with vascular invasion [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(4): 364-367.
[5] ZHANG Yuping, SONG Lei, LI Chunyan, et al. LINC00221 promotes proliferation,migration and invasion in hepatocellular carcinoma through ERK signaling pathway [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(11): 1037-1040.
[6] YANG Jun, SUN Long, ZHAO Jianquan, et al. Relationship of plant homeodomain finger protein 2 expression with clinicopathological features and prognosis in hepatocellular carcinoma [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(11): 1041-1043.
[7] . Clinical application of autologous tumor infiltrating lymphocytes combined with antiPD1 antibody in the treatment of advanced hepatocellular carcinoma [J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(8): 743-747.
[8] . Effect on liver hyperplasia and hepatocellular carcinoma growth after liver arterial ligation combined with partial portal ligation [J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(4): 367-371.
[9] LI Jiang, HUANG Zhiyong.. Advances in immune microenvironment and immunotherapy of hepatocellular carcinoma [J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(11): 1089-1091.
[10] ZHANG Weiyi, XIA Wei, YUAN Guangchao, et al.. Sevoflurane inhibits the proliferation,invasion and migration of hepatocellular carcinoma cells through BACE1-AS and glycolysis [J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(10): 985-989.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 744 .
[2] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 769 .
[3] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 772 .
[4] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 774 .
[5] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 792 .
[6] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 804 .
[7] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 802 .
[8] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 807 .
[9] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(11): 809 .
[10] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(11): 812 .